Integrating Research with Clinical Practice:
-
Dr. Lakhanpal’s clinical practice seamlessly integrates cutting-edge research with patient care
-
His work at Rheumatology Associates and contributions to the Metroplex Clinical Research Center have redefined evidence-based rheumatology
-
By translating research findings into actionable treatment protocols, he has significantly improved outcomes and quality of life for patients
Dr. Sharad Lakhanpal has been honored with the prestigious Pravasi Bharatiya Samman Award (PBSA) for 2025, recognizing his exceptional contributions to medical science. The PBSA is the highest honor conferred on overseas Indians, celebrating remarkable achievements across diverse fields. This accolade underscores Dr. Lakhanpal’s transformative impact on rheumatology and his commitment to advancing healthcare and equality in the United States.
The award was presented during the 18th Pravasi Bharatiya Divas (PBD) Convention held in Bhubaneswar, Odisha, from January 8 to 10, 2025. President of India, Droupadi Murmu, conferred the honor during the Valedictory Session, symbolizing the enduring bond between India and its global diaspora.
Academic Foundation and Early Excellence
Dr. Lakhanpal’s journey to medical excellence began at King George’s Medical College, University of Lucknow, India, where his academic prowess earned him numerous gold medals and accolades. These early achievements laid a strong foundation for his future endeavors. Pursuing advanced training in the United States, he completed his Internal Medicine residency at Memorial Hospital, University of Massachusetts Medical School, followed by a specialized Rheumatology fellowship at the renowned Mayo Clinic in Minnesota.
Professional Development and Leadership
In 1987, Dr. Lakhanpal joined Rheumatology Associates, embarking on a distinguished clinical career. Dual board-certified in rheumatology and internal medicine, he has provided holistic patient care by addressing both specific rheumatological conditions and overall health. As a Clinical Professor of Internal Medicine at UT Southwestern Medical Center, he has mentored countless medical students, residents, and fellows, fostering the development of future medical leaders.
Pioneering Research and Innovation
Dr. Lakhanpal’s role at the Metroplex Clinical Research Center in Dallas has been pivotal in advancing rheumatological research. His involvement in hundreds of clinical trials has led to groundbreaking treatments for rheumatic diseases, focusing on:
- Developing novel therapeutic agents
- Investigating innovative treatment approaches
- Evaluating drug efficacy and safety
- Assessing long-term outcomes of rheumatic conditions
These contributions have set new benchmarks in rheumatology, enhancing patient care globally.
Professional Leadership
In 2017, Dr. Lakhanpal was elected President of the American College of Rheumatology, marking a significant milestone in his career. In this esteemed role, he Championed policy development in rheumatology care, advanced professional education initiatives, fostered international collaborations, and advocated for research and innovation.
He also promoted improved patient care standards and worked as global educator and mentor.
Dr. Lakhanpal’s influence extends beyond the clinical and research arenas. As an educator, he has delivered lectures on international platforms, engaging medical communities worldwide. At UT Southwestern Medical Center, his comprehensive approach to education bridges theoretical knowledge with practical clinical applications. His legacy includes training a generation of rheumatologists who carry forward his principles of excellence and compassion.
Recognition and Legacy
The Pravasi Bharatiya Samman Award 2025 celebrates Dr. Lakhanpal’s lifelong dedication to advancing medical science, education, and patient care. His illustrious career exemplifies the profound impact of Indian medical professionals on global healthcare. A symbol of excellence and innovation, Dr. Lakhanpal’s achievements continue to inspire the next generation of healthcare leaders.
***********************************************************
Readers
These are extraordinary times. All of us have to rely on high-impact, trustworthy journalism. And this is especially true of the Indian Diaspora. Members of the Indian community overseas cannot be fed with inaccurate news.
Pravasi Samwad is a venture that has no shareholders. It is the result of an impassioned initiative of a handful of Indian journalists spread around the world. We have taken a small step forward with the pledge to provide news with accuracy, free from political and commercial influence. Our aim is to keep you, our readers, informed about developments at ‘home’ and across the world that affect you.
Please help us to keep our journalism independent and free.
In these difficult times, running a news website requires finances. While every contribution, big or small, will make a difference, we request our readers to put us in touch with advertisers worldwide. It will be a great help.
For more information: pravasisamwad00@gmail.com